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Abstract: The activity and inducibility of cytochrome P450 systems (CYP1A1:1A2) of the human placenta 
were assessed in a representative human trophoblast-like cell line, BeWo.  The activity of CYP1A1 and 
CYP1A2 in microsome preparations from human liver, placenta, primary cultures of human 
cytotrophoblast, and BeWo cells was measured by O-dealkylation of 7-ethoxyresorufin (EROD) and 7-
methoxyresorufin O-demethylation (MROD), respectively.  Results indicated high EROD and MROD 
activity associated with human liver microsomes, sometimes comparable activities in human placenta 
microsomes prepared from smokers, and relatively low activities in human placenta microsomes from 
nonsmokers and in the primary cultures of cytotrophoblasts isolated from nonsmokers.  Microsomes 
from BeWo cell monolayers exhibited the lowest EROD and MROD activities relative to all other 
microsome preparations. However, compared to primary cultures of normal trophoblasts, the EROD 
activity of the BeWo cells was far more sensitive to typical inducers, 3-methylcholanthrene, 1,2-
benzanthracene, and β-naphthoflavone.  EROD activity in BeWo cells was induced approximately 200-
fold by 3-methylcholanthrene.   Both EROD and MROD activity in BeWo cells was readily induced by 1,2-
benzanthracene, 100-fold and 60-fold, respectively.   After induction with 1,2-benzanthracene, the 
CYP1A1 selective inhibitor, α-naphthoflavone, and the CYP1A2 selective inhibitor, furafylline, effectively 
inhibited enzyme activities with IC50’s of 2.4µM and 12.8µM, respectively, in microsomes from both 
trophoblasts culture systems.  These results show that major cytochrome P450 forms present in human 
placenta are present and inducible in BeWo cells, a potential model for investigation of drug metabolism 
mechanisms in the human trophoblast.  
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INTRODUCTION 
Cytochrome P450 systems in the human placenta are induced by polycyclic hydrocarbons 
present in cigarette smoke resulting in altered steroid or xenobiotic metabolism (Pasanen et al., 1990; 
Pasanen and Pelkonen, 1990; 1994; Lee and Riddick, 2000).  Polycyclic aromatic hydrocarbons are 
substrates for cytochrome P450 form 1A1 (CYP1A1) and exposure to these molecules correlates with 
low birth weight in man and in other species (Khera el al., 1972; Shum et al., 1979; Allen and Barsotti, 
1976). The CYP1A subfamily is primarily extrahepatic and includes types 1A1 and 1A2 which are about 
70% homologous in amino-acid sequences (Nerurkar et al., 1993). 
Human CYP1A1 and CYP1A2 forms are under the regulation of the Ah locus and retain activity 
toward polycyclic aromatic hydrocarbons.  The CYP1A2 form preferentially  retains activity toward 
aromatic and heterocyclic amines (Butler et al., 1989). CYP1A1 is the more persistent of several P450 
forms present throughout pregnancy (Hakkola et al., 1996a; 1996b). By contrast, CYP1A2 has a relatively 
minor constitutive expression in the human placenta (Pasanen and Pelkonen, 1994). Considering the 
role of cytochrome P450 in drug metabolism, there is a need to develop models to elucidate the 
significance of drug interactions with human placenta enzymes in situations where the mother is 
exposed to tobacco smoking and other environmental conditions (Pasanen and Pelkonen, 1994; Zevin 
and Benowitz, 1999). 
The objective of  this study was to characterize the activity and inducibility of selected 
cytochrome P450 systems, CYP1A1:1A2, in microsomes from representative in vitro trophoblast systems 
including a human trophoblast-like cell line, BeWo. The presence of inducible CYP1A1 and CYP1A2 forms 
in appropriate in vitro systems would provide useful tools to study environmental factors, drugs, drugs 
of abuse effects on the metabolism in the human trophoblast. Cytochrome P450 activity in the 
microsomes prepared from the placenta of smokers, the placenta of nonsmokers, primary cultures of 
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cytotrophoblasts isolated from the placenta of nonsmokers, and the BeWo cells was measured by O-
dealkylation of specific substrates for CYP1A1, 7-ethoxyresorufin, and CYP1A2, methoxyresorufin 
(Dutton and Parkinson, 1989). To verify inducibility of metabolism, BeWo cell monolayers and primary 
cultures of human cytotrophoblasts were exposed to CYP1A1:A2 inducers, 3-methylcholanthrene, 1,2-
benzanthracene, and β-naphthoflavone.  We also explored the effects of a specific CYP1A1 inhibitor, α-
naphthoflavone, on 7-ethoxyresorufin O-dealkylation (EROD), and a specific mechanism-based CYP1A2 
inhibitor, furafylline, on 7-methoxyresorufin O-demethylation (MROD) in the BeWo cell system.  
 
MATERIALS  AND METHODS 
 
BeWo cell culture.   
 
The BeWo cell line was originally derived from a human choriocarcinoma (Pattillo and Gey, 
1968; Pattillo et al., 1979).  The BeWo (b30) was obtained from Dr. Alan Schwartz (Washington 
University, St. Louis, MO) and grown in culture as detailed in earlier work (Liu et al., 1997; Kenagy et al., 
1998). Briefly, BeWo cells were continuously cultured in DMEM with 10% heat-inactivated FBS 
containing 0.37% sodium bicarbonate and 1% antibiotics (10,000 U/ml penicillin and 10 mg/ml 
streptomycin).  The cells were routinely maintained in 150 cm Corning flasks at pH 7.4 under 5% CO2 and 
95% humidity at 37°C.  The cells were harvested by brief exposure (2-3 minutes) to a trypsin EDTA 
solution (0.25% trypsin and 0.02% EDTA in PBS). The culture medium was exchanged every 48 hours. 
Consistency in exponential growth required 1:10 split for each passage. The passages used for the 
following experiments were 22-38.   
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Human cytotrophoblast cell culture 
The study protocol and use of human placentas in this work was approved by the University of 
Kansas Advisory Committee on Human Experimentation (ACHE#8904). 
Term placentas were received from unremarkable pregnancies of anonymous volunteers who indicated 
that they were either nonsmokers or smoked on a regular basis. Except for placentas used for cell 
isolation and primary cell culture described below, placentas were washed with ice-cold normal saline 
and immediately frozen at –70°C after delivery. For each preparation, placenta tissue was sampled from 
three to four delivered term placentas from mothers who indicated either that they were non-smokers 
or smoked cigarettes on a regular basis.  For preparation of primary cultures, purified human 
cytotrophoblasts were isolated by the methods of enzymatic digestion and Percoll gradient 
centrifugation (Kenagy et al., 1998). The partially purified cytotrophoblasts were collected washed once 
with DMEM and resuspended with plating media consisting of DMEM with 10% fetal bovine serum. 0.1% 
mg/ml L-glutamine and 50 µg/ml gentamicin. 
 
Microsome preparation 
Microsomal fractions from BeWo cells were prepared according to Hakkola et al. (1996a).  
Briefly, the cells were grown in 150-cm flasks until confluent monolayers were formed. The cells were 
rinsed with phosphate-buffered saline, pH 7.4, and bathed in a buffer containing 50mM Tris-HCL, pH 7.4, 
150 mM KCl, and 2 mM EDTA. The cells were removed from the flasks and homogenized with a glass 
homogenizer in a 1:4 vol of  0.1 M sodium potassium phosphate buffer (pH 7.4) containing 20% (v/v) 
glycerol.  Cell extracts were centrifuged at 1000g for 10 minutes and the supernatant was centrifuged at 
10,000g for 30 minutes. The resulting supernatant was centrifuged at 100,000g for 60 minutes. The 
supernatant from the last spin was discarded and the microsomal pellet was suspended in 0.25 M 
sucrose and stored at –70°C.  
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Western blots 
Microsomes prepared from BeWo cells, cytrophoblasts, and whole placental tissue from 
smokers and nonsmokers (0.5 µg protein) and were subjected to SDS-PAGE, 12% acrylamide Tris-glycine. 
Microsomal proteins were transferred electrophoretically to polyvinylidene difluoride (PVDF) 
membranes for 6 hours with a 35mA current. A 10% nonfat dry milk and 2% bovine serum albumin 
solution in 10mM Tris-HCl, pH 7.4, was used to block nonspecific binding. Microsomal P450 was 
detected by CYP1A1/CYP1A2 (10 µg/ml) polyclonal antibody (Xentotech, Kansas City, KS) and CYP1A2 
(10µg/ml) monoclonal antibody (Gentest, Woburn, MA). Antibody solutions were prepared in 10 mM 
Tris-HCL, pH 7.4, containing 0.05% Tween 20. Secondary antibody, anti-mouse IgG (Fab) peroxidase 
conjugate was prepared 1:80,000 fold in 10 mM Tris-HCl containing 0.05% Tween 20 and incubated with 
PVDF membrane for 1 hr at 25°C. CYP1A1 and CYP1A2 were detected by enhanced chemiluminescence 
by incubating PVDF immunoblots at 25°C for 1 minute and exposure to Hyperfilm-HCL.  
 
Enzyme assays (EROD and MROD) 
Microsomal cytochrome P450 activity was measured fluorometrically by O-dealkylation of  7-
ethoxyresorufin (EROD) and O-demethylation of 7-methoxyresorufin (MROD) producing resorufin 
(Dutton and Parkinson, 1989). Reaction mixtures of 1 ml final volume were incubated at 37°C. The 
reaction mixture contained potassium phosphate buffer (100mM, pH 7.4), MgCl (3 mM), EDTA (1 mM), 
NADPH (1.0 mM), glucose 6-phosphate (5.0 mM), glucose 6-phosphate dehydrogenase (1 unit/ml) and 
7-ethoxyresorufin/ methoxyresorufin (2.5 mM in DMSO). Blanks did not contain NADPH.  Reactions 
were initiated by adding NADPH and stopped after 8 minutes with 2 ml acetone. Cellular protein was 
removed by centrifugation at 1000g for 10 minutes and the supernatant transferred to cuvettes.  
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Fluorescence was measured at an emission of 590 nm and the excitation at 530 nm in an SLM-Aminco 
4800 spectrofluorometer.    
 
In vitro Induction of CYP1A1:1A2 
7-Alkoxyresorufin O-dealkylase and 7-Methoxyresorufin O-demethylation activities were 
measured by the fluorometric method of Burke and Mayer with modifications (Burke et al., 1978; 1985). 
BeWo cells were seeded at a density of 1.6 x 105 cells/cm2 in six well-plates (Nunclon). Experiments were 
conducted when the cells formed confluent monolayers and all experiments were conducted in culture 
medium. The cells were washed three times with PBS and treated with 10 µM dicumerol [3,3’-
methylene-bis(4-hydroxycoumarin)] and 8 µM of either 7-ethoxyresorufin or 7-methoxyresorufin. The 
cells were incubated at 37°C for 30 minutes. After the incubation, a 750-µl aliquot of culture medium 
from each well was removed and placed in a glass test tube and 250 µl of a β-glucuronidase (15 Fishman 
U)/arylsulfatase (120 Roy U) solution in 0.1 M sodium acetate (pH 4.5) was added to each test tube.  The 
test tubes were incubated for 2 hours at 37C.  A 2.0-ml aliquot of 95% ethanol was then added to each 
test tube and the samples were centrifuged for 10 minutes at 3000 rpm.  A 2-ml sample of the 
supernatant was placed in a cuvet for fluorescence detection (SLM fluorometer, excitation 530 nm, 
emission 590 nm). The amount of resorufin formed in the reaction was determined based on a resorufin 
standard curve and corrected for the volume in the original sample. A BCA protein assay (Pierce) was 
conducted on the monolayers in order to calculate the amount of resorufin formed per milligram 
protein.  To measure 1,2-benzanthracene, 3-methylcholanthrene, and β-napthoflavone induction of 
CYP1A1:1A2 BeWo cells were treated 24 and 48 hours prior to assaying EROD and MROD. Inhibitory 
effects of α−naphthoflavone (7,8-benzoflavone) on CYP1A1 and furafylline on CYP1A2 were studied in 
BeWo cells after 24 hours exposure to 100µM of 1,2-benzanthracene.  
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Statistical analysis 
An ANOVA followed by a Tukey’s multiple comparisons test was applied to the data in this 
study.   Where appropriate, statistical differences were indicated by a P-value of less than 0.05.   Data 
are expressed as mean + standard error of the mean (SEM).  
 
RESULTS 
Microsomes were prepared from liver, placenta from mothers who indicated they smoked 
cigarettes on a regular basis, placenta from nonsmokers, primary cultures of human cytotrophoblasts 
isolated from the placenta of nonsmokers, and BeWo cell monolayers.  The microsomes were assayed 
for EROD and MROD activity based on resorufin formation and results are summarized in Table 1.  The 
liver exhibited the greater EROD and MROD activities in microsomes as expected, however, activities in 
the placentas from smokers approached the liver at least with respect to EROD activity in some 
instances.  Samples were collected from multiple placentas and two pools were created to show the 
variability in induction that was observed in the placentas from smokers.   EROD and MROD activities in 
microsomes prepared from the placentas of nonsmokers were consistently low.  Microsomes prepared 
from human cytotrophoblasts isolated from placentas of nonsmokers grown in primary culture also 
retained low EROD activity comparable to the levels observed in samples from placental tissue samples 
of nonsmokers.   The BeWo cells exhibited consistently low EROD and MROD activity overall. 
In primary culture, isolated human cytotrophoblasts from the placentas of nonsmokers were 
shown to retain the low levels of EROD activity as indicated in Table 1.  In these studies, EROD activity in 
the primary cultures was assayed after 8 days in culture with monolayers that were approximately 60% 
confluent.  As illustrated in Figure 1, EROD activity was modestly altered in these primary cell cultures by 
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the inducers 3-methylcholanthrene and β-naphthoflavone. Both inducers produced increases in EROD 
maximally of about 2-fold.  
Based on the modest inducibility of the primary cultures, further experiments were carried out 
with the BeWo cell line which showed a greater response to the individual inducers. The BeWo cells 
exhibited basal EROD and MROD activity that was lower than the primary cultures of human 
cytrophoblasts and activity observed in microsomes from placentas of nonsmokers (Table 1). By 
contrast, however, BeWo cells were far more responsive to selected inducers than the primary cultures 
of human cytotrophoblasts.  3-methylchloranthrene, β-naphthoflavone, and 1,2-benzanthracene 
induced EROD and MROD activity in BeWo cells in a dose-dependent manner following a 24 hour 
treatment.   Induction of EROD by 3-methylcholanthrene was concentration-dependent and nearly 200-
fold over the control activity as also presented in Figure 1.   The EC50 for 3-methylcholanthrene induction 
was 5.2 µM as calculated by nonlinear regression.   β-naphthoflavone induction of EROD activity in 
BeWo cells is summarized in Figure 2. At higher concentrations of the inducer, a maximal induction of 
about 20-fold was observed with β-naphthoflavone alone and approximately 50-fold when applied in 
combination with dexamethasone.   
Immunoblotting experiments shown in Figure 3A, indicate CYP1A1 and CYP1A2 
immunoreactivity from microsomes isolated from primary cultures of cytotrophoblasts (lane 3) 
compared to microsomes from whole placental tissue of nonsmokers (lane 1), microsomes from whole 
placental tissue samples from smokers (lane 2) and microsomes from rat liver as a positive control (lane 
4).  Blots for microsomal protein from the primary cultures were qualitatively similar to the whole 
placental tissue sample for nonsmokers.   Confirmation of inducible CYP1A1:1A2 in cytotrophoblasts by 
was observed in microsomal protein obtained from cells harvested 8 days post seeding in vitro and is 
illustrated in Figure 3B.   CYP1A1 and CYP1A2 immunoreactivity from cytotrophoblast microsomes of 
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primary cultures from nonsmokers (lane 1) was visibly enhanced relative to the immunoreactivity from 
cytotrophoblast microsomes of primary cultures microsomes from whole placenta of nonsmokers (lane 
3) in Figure 3A, and microsomes from whole placenta of maternal smokers (lane 1) in Figure 3A.   The 
immunoreactivity in the positive controls, microsomes from whole placenta of smokers (lane 2), 
microsomes form rat liver-induced with 3-methylcholanthrene (lane 3) and non-induced human liver 
(lane 4) were relatively strong as illustrated in Figure 3B.  
To verify induction of CYP1A1:1A2 in BeWo cells, the cells were to exposed to chemical inducers 
for 72 hours.  In Figure 4, relative to 3-methylcholanthrene induced rat liver microsomes (lane 1), 
uninduced BeWo microsomes (lane 2) are shown alongside protein from microsomes from cells induced 
with 10µM of 3-methylchloranthrene (lane 3), or 10µM of β-naphthoflavone (lane 4), or 10µM of 1,2-
benzanthracene (lane 5).   Immunoreactive CYP1A1 was observed to be inducible to a significant degree 
by two of the three compounds tested with optimal response by 3-methylchloranthrene and a lesser 
response by 1,2-benzanthracene.  
Figure 5 shows preferential 1,2-benzanthracene induction on EROD activity compared to MROD 
activity in the BeWo cells.  At higher concentrations, 1,2-benzanthracene induced EROD and MROD 
activity by about 100- and 60- fold, respectively over control levels.  Phenobarbital a classic inducer of 
CYP2B1 has been shown to increase 7-pentoxyresorufin O-dealkylase (PROD; a substrate for CYP2B1) 
but not EROD activity in brain microsomes (Dhawan et al., 1999). In BeWo cells induction by a 24 hour 
exposure to 100 µM phenobarbital increased MROD activity about 30-fold  (12.7 + 1.0 pmol/mg/min) 
compared with a more modest 2.5-fold stimulation of PROD (1.0 + 0.3 pmol/ml/min).  Induction of EROD 
by phenobarbital was not observed in BeWo cells (data not shown).     
To establish that the induced EROD and MROD activities were specific to CYP1A1 and CYP1A2, 
we looked at the effects of specific inhibitors, 7,8-benzoflavone (or α-naphthoflavone) and furafylline, 
Avery, M.L., Meek, C.E., and Audus, K.L. (2003) The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell 
line.  Placenta 24, 45-52.  PMID: 12495659.  Publisher’s official version: <http://dx.doi.org/10.1053/plac.2002.0876>.  Open 
Access version:  http://kuscholarworks.ku.edu/dspace/. 
10 
 
respectively, following induction by 100 µM 1,2-benzanthracene for 24 hours. Results summarized in 
Figure 6 shows 7,8-benzoflavone effectively inhibited EROD activity, IC50 = 2.4 µM, and furafylline 
inhibits MROD activity, IC50 = 12.8 µM, respectively.  
 
DISCUSSION 
 
The enzyme activities of 7-ethoxyresorufin 0-dealkylase and 7-methoxyresorufin 0-
demethylation were measured to study induction and inhibition mechanisms of CYP1A1 and CYP1A2, 
respectively in placental tissues and trophoblast culture systems.  It has been reported that EROD is 
represented by CYP1A1 and CYP1A2 ( Eugster et al., 1993; Shimada et al., 1997; Nakajima et al., 1999).   
Several reports suggest MROD is a suitable marker of CYP1A2 (Nerurkar et al., 1993; Iba et al, 1999; 
Sakuma et al., 1999).  
Ex vivo placenta microsomes were compared in two parallel studies and were based on the 
predetermined indication of regular maternal smoking without knowing the number or duration of 
cigarette smoking. Observed EROD and MROD levels measured in two pooled microme samples, each 
sample representing three to four different placentas.  We observed significant differences in EROD and 
MROD activities among maternal smokers and nonsmokers.   These studies suggested that inducible 
CYP1A1 and CYP1A2 are present in the human placentas surveyed here.   Our results were consistent 
with previous reports that showed EROD and aryl hydrocarbon hydroxylase levels up to a 100-fold 
greater in placenta exposed to maternal smoking.  Moreover, the magnitude of the activities found here 
as well as the variability of different sample pools from placenta was consistent with earlier studies 
reported for both smokers and nonsmokers (Pasanen et al., 1988; 1990; Hakkola et al., 1996a; Lee and 
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Riddick et al., 2000).   These observations for the basis for identifying cell culture systems that retain a 
similar expression and activity of major enzymes as well as the sensitivity to known chemical inducers. 
In cytotrophoblasts isolated from term placenta and grown in primary culture, inducible CYP1A1 
was increased by less than 2-fold by 3-methylcholanthrene and only 2- to 2.4-fold by β-naphthoflavone.  
These results may be due to absence of confluency of primary cells, the percentage of cells that adhere 
to cell culture plates, and or simply the magnitude of inducible P-450 enzymes in vitro (Madan et al., 
1999).   As a result of the modest responsiveness of the primary cultures, we pursued studies with the 
BeWo cell line which responded impressively to known chemical inducers.   A 200-fold induction of 
CYP1A1 by 3-methylcholanthrene in BeWo cells was observed and the effect was concentration 
dependent with an estimated EC50 of ~5.16 µM.   Studies with BeWo cells also indicated that 
dexamethasone increased the induction produced with β-naphthoflavone treatments.  Previously, 
transcriptional regulation of AhR-mediated pathway induction with dexamethasone has been reported 
(Mathis et al., 1986; Prough et al., 1996). Results in that study supported the idea that CYP1A1 was 
induced by aryl hydrocarbons via a AhR-mediated pathway.  In our study, we report a 51-fold increase in 
EROD after induction with dexamethasone and β-naphthoflavone compared with a 24-fold increase with 
β-naphthoflavone.  Accordingly, our results support the possible role of the AhR-mediated pathway in 
the induction of BeWo cell EROD.     
Northern blot analysis using mouse CYP1A1 cDNA has confirmed rat hepatic CYP1A1 (~2.7 Kb) 
and CYP1A2 (~2.0 Kb) induction after 6 hours post-dose with 3-methylcholanthrene (Lee and Riddick, 
2000).  In time course studies, a single intrapertioneal dose of 3-methylcholanthrene (40mg/Kg) in 
rodents also resulted in a 179-fold increase in CYP1A transcription after 6 hours (Lee and Riddick, 2000).  
These results were also supported by findings that transcriptional rates of CYP1A1 and CYP1A2 increased 
by 3-hours and were maximal 12 hours after 3-methylcholanthrene exposure (Lee and Riddick, 2000). In 
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BeWo cells, inducible CYP1A1:1A2 was maximal after 24 hours induction with 3-methylcholanthrene.    
Apparent cell degradation was observed post 24 hours with 3- methylcholanthrene (data not shown).   A 
decrease in EROD and MROD levels were observed in BeWo cells after a 24 hours exposure to 1,2-
benzanthracene. Consequently, the time course for maximal in vitro induction was 24 hours or less and 
was apparently somewhat slower than the time course for maximal induction in rodents. 
Immunoblots confirmed CYP1A1:1A2 induction in placentas obtained from smokers. Our results 
were in agreement with immunoblots from induced microsomes from rodent liver exposed to dose-
dependent nicotine feeding (Iba et al., 1999).    The immunoblots confirmed retention of a modest 
induction of enzyme expression in primary cultures of cytotrophoblasts from nonsmokers following 
treatment with 10 µM of 3-methylcholanthrene.    Additionally, immunoblotting confirmed induction by 
3-methylcholanthrene in microsomes isolated from BeWo cells.  Induction of BeWo cells with β-
napthoflavone and 1,2-benzanthracene also increased immunoreactive CYP1A1, however less than 
observed with 3-methylcholanthrene.   The qualitative observations of the immunoblots for CYP1A1:1A2 
are in general agreement with the biochemical data in this study.  
Many P450 chemical inhibitors are well characterized in primary cell cultures of hepatocytes 
(Pichard et al., 1990).   To assess the contributions of CYP1A1 and CYP1A2 to EROD and MROD measures 
in BeWo cells, we used to known inhibitors following exposure to 1,2-benzanthracene.    In BeWo cells, 
effective inhibition of CYP1A1 by 7,8-benzoflavone and CYP1A2 by furafylline was observed 24 hours 
after induction with 1,2-benzanthracene.  Results show that 7,8-benzoflavone inhibited 7-
ethoxyresorufin O-deethylase by approximately 80% with an apparent IC50 of 2.4 µM.   Furafylline, a 
mechanism-based inhibitor specific for  CYP1A2, inhibited methoxyresorufin O- demethylation by 
greater than 70% with an observed IC50 of 12.8 µM.     Previously, Sesardic et al. (1990a;1990b), reported 
furafylline inhibited human placenta phenacetin O-deethylase with an IC50 of 46µΜ.   Therefore, 
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considering the extent of inhibition together with the IC50 values suggest that 7,8-benzoflavone is a 
strong inhibitor of CYP1A1 enzymatic activity and furafylline is a moderate inhibitor of CYP1A2 and 
MROD.   Our data would suggest that BeWo cells may be a suitable matrix to screen compounds using 
competitive and mechanism based inhibitors of these enzymes although additional studies are required 
to further validate our observations.  
Hakkola et al. (1996b) detected CYP1A1:A2 mRNA during the first trimester without significant 
CYP1A2 mRNA at term.   Results reported herein suggest inducible CYP1A1 levels in cytotrophoblasts 
from term placenta and BeWo cells consistent with that work.  By contrast, our studies confirm CYP1A2 
protein and enzymatic activity from placenta based on immunoblotting and inducible CYP1A2 
demethylation.    In BeWo cells, induction of CYP1A2 with phenobarbital increased MROD 30-fold.  
Induction studies with phenobarbital exposure in rodent livers have been shown to have 
immunoreactivities  with CYP1A1:A2 antibodies (Sakuma, et al., 1999).    In other rodent studies, 
phenobarbital induced CYP1A2 and further demonstrated in rodent primary hepatocytes that CYP1A2 
transcription and enzyme levels are inducible with exposure to phenobarbital (Nemoto and Sakurai, 
1995; Sakuma et al., 1999).  Moreover, CYP1A2 has been subsequently suggested to be a member of the 
phenobarbital-inducible genes in mice and that the AhR-mediated pathway does not play a role in the 
induction (Sakuma et al., 1999).   Similarly, In a recent communication, CYP1A2 induction was 
demonstrated in Hepa-1 cells, a hepatocyte cell line (Sindhu et al., 2000).  In HEPG2 cells, another 
hepatocyte cell line, CYP1A1 was detectable after induction by polycyclic aromatic hydrocarbons (PAH), 
however,  CYP1A2 was not detectable after PAH induction (Vakharia et al., 2001).    Thus, in liver CYP1A2 
expression has been extensively studied in vivo, ex vivo, and in vitro and other reports describe the 
presence of CYP1A2 in other tissues including the brain and with cultured umbilical vein endothelium 
(Farin and Omiecinski, 1993; Farin et al., 1994; McDonnell et al., 1992; Sindhu et al., 2000).  It is not 
surprising that CYP1A2 is inducible in a placental cell line.   The degree to which CYP1A2 is expressed and 
Avery, M.L., Meek, C.E., and Audus, K.L. (2003) The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell 
line.  Placenta 24, 45-52.  PMID: 12495659.  Publisher’s official version: <http://dx.doi.org/10.1053/plac.2002.0876>.  Open 
Access version:  http://kuscholarworks.ku.edu/dspace/. 
14 
 
functional in a given tissue such as the placenta at term may depend on the type and prior chemical 
exposures as previously proposed by Pasanen and Pelkonen (1994). 
In summary, comparisons shown with primary cytotrophoblasts and placenta microsomes from 
maternal smoking that  inducible CYP1A1/A2 activities are present at term.  BeWo cells retain low 
CYP1A1/A2 activity that is consistent with the placenta of nonsmokers.  However, data reported in these 
studies show CYP1A1/A2  are readily inducible in BeWo cells and implies that this system may be a good 
model for studying CYP1A1/A2 induction in the human trophoblast.  
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FIGURE LEGENDS 
 
Figure 1. Induction of CYP1A1 in microsomes prepared from either BeWo cells or primary cultures of 
human cytotrophoblasts isolated from placentas of non-smokers.   7-Ethoxyresorufin O-dealkylase 
activity was measured after 24 hours pretreatment with indicated concentrations of either 3-
methylchloranthrene (3-MC) or β-naphthoflavone (β-NF).  Data points represent the mean ± the 
standard deviation for at least three different preparations of microsomes.   Solid diamonds: BeWo cells 
induced with 3-MC; solid squares: primary cultures of cytotrophoblasts induced with 3-MC; solid 
triangles: primary cultures of cytotrophoblasts induced with β–NF. 
 
Figure 2.  Induction of CYP1A1 in BeWo cell microsomes after 24 hour pretreatment of the cells with 
dexamethasone, β-naphthoflavone, or the combination of the agents.  Data points represent the  mean 
± the standard deviation for 7-Ethoxyresorufin O-dealkylase activity in at least three different 
preparations of microsomes.  
 
Figure 3.   (A) Immunoblot of CYP1A1/2 microsomal protein (5.0 µg) isolated from whole human 
placenta of nonsmokers (Lane 1), smokers (Lane 2), 8-day old primary cultures of cytotrophoblasts 
isolated from nonsmokers (Lane 3), and 0.5 µg rat liver (lane 4) .   (B) Immunoblot of CYP1A1/2 
microsomal protein (5.0 µg) isolated from primary cultures of cytotrophoblasts from human placenta of 
nonsmokers induced with 10 µM 3-methylcholanthrene for 24 hours (Lane 1), primary cultures of 
cytotrophoblasts from smokers (Lane 2), 0.5 µg rat liver induced with 3-methylcholanthrene (Lane 3), 
and human liver (Lane 4).   
 
Figure 4. Immunoblot of microsomal protein (5.0 µg) isolated from BeWo cells exposed 24 hours to 
selected inducers.    Lane 1, rat liver induced with 3-methylchloranthrene; Lane 2, BeWo cells treated 
with inducer solvent, DMSO;  Lane 3, BeWo cells induced with  3-methylchloranthrene; Lane 4, BeWo 
cells induced with 1,2-benzanthracene; and Lane 5, BeWo cells induced with α-naphthoflavone. 
 
Figure 5. Induction of CYP1A1 in BeWo cell microsomes after 24 hour pretreatment of the cells with 1,2-
benzanthracene.  Data points represent the  mean ± the standard deviation for 7-Ethoxyresorufin O-
dealkylase activity in at least four different preparations of microsomes. 
 
Figure 6.  Concentration-dependent inhibition of 1,2-benzanthracene induced CYP1A1 and CYP1A2 in 
BeWo cell microsomes by either α-naphthoflavone or furafylline.   Enzymes, 7-ethoxyresorufin O-
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dealkylase (EROD) and 7-methoxyresorufin O-dealkylase (MROD) were induced by a 24 hour 
pretreatment of the cells with 1,2-benzanthracene.    Data points represent the mean ± the standard 
deviation of control EROD and MROD activity remaining following inhibition by either α-naphthoflavone 
and furafylline, respectively, in at least four different preparations of microsomes.   The IC50’s  for α-
naphthoflavone and furafylline were approximately 2.4 μM and 12.8 μM, respectively. 
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Table 1.  Activity of 7-ethoxyresorufin deethylases (EROD) and 7-methoxyresorufin O-dealkylase 
(MROD) in microsomes prepared from human liver, placenta, and human cell culture systems.     
  Resorufin  (pmol/mg/min)  
Microsomes Samples 
EROD MROD 
Human liver n = 11 42.5  ± 0.6* 39.6  ± 2.5* 
Human placenta from smokers n = 4 46.0  ± 4.4* 5.4  ± 0.5* 
Human placenta from smokers n = 4 18.9  ± 0.6* 14.7  ± 1.1* 
Human placenta from nonsmokers n = 3 3.4  ± 1.7 3.7  ± 1.4 
Human placenta from nonsmokers n = 3                                  1.7 ± 0.7 2.4  ± 0.6 
Primary cultures of  human cytotrophoblasts  n = 3 2.48  ± 0.4 - 
BeWo cell monolayers n = 3 0.45 ± 0.01* 0.40 ± 0.02* 
Experiments were carried out with samples taken from indicated numbers (n) of different tissues or 
monolayers.   The data represent the means ± standard deviation.   * P < 0.05, data significantly 
different form both pools of data for human placenta from nonsmokers.  
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Figure 1, Avery et al. 
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Figure 2, Avery et al. 
 
 
 
0
5
10
15
20
25
E
R
O
D
(p
m
ol
/m
g/
m
in
)  
 
DMSO      1 μM Dex    10 μM β-NF    1μM Dex    50 μM β-NF  1 μM Dex 
                                                       +10 μM β-NF                      +50 μM β-NF                               
Avery, M.L., Meek, C.E., and Audus, K.L. (2003) The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell 
line.  Placenta 24, 45-52.  PMID: 12495659.  Publisher’s official version: <http://dx.doi.org/10.1053/plac.2002.0876>.  Open 
Access version:  http://kuscholarworks.ku.edu/dspace/. 
26 
 
 
Figure 3, Avery et al. 
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Figure 4, Avery et al. 
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Figure 5, Avery et al. 
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Figure 6, Avery et al.  
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